NCT01694329View on ClinicalTrials.gov

Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada

UnknownOBSERVATIONAL

Enrollment

1,420

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Acute Upper Respiratory InfectionAcute Lower Respiratory Tract InfectionOtitis Media (OM)Invasive Pneumococcal Disease, Protection Against

Trial Locations (1)

G1R 3L5

Centre de recherche du CHUQ, Québec

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

CHU de Quebec-Universite Laval

OTHER